Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
Antonio Matrone, Carla Gambale, Alessandro Prete, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities
Lizhuo Zhang, Qingqing Feng, Jiafeng Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188928-188928
Open Access | Times Cited: 33
Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?
Krzysztof Kaliszewski, Maksymilian Ludwig, Bartłomiej Ludwig, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3643-3643
Open Access | Times Cited: 34
The Role of Lipid Metabolism Disorders in the Development of Thyroid Cancer
Martyna Łukasiewicz, Agata Zwara, Jacek Kowalski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7129-7129
Open Access | Times Cited: 6
Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment
Alessandro Prete, Carla Gambale, Liborio Torregrossa, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 8, pp. e613-e622
Closed Access | Times Cited: 11
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma
Alessandro Prete, Liborio Torregrossa, Carla Gambale, et al.
Thyroid (2025)
Closed Access
Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer
Laura Valerio, Antonio Matrone
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Characteristics of RET gene mutations in Vietnamese medullary thyroid carcinoma patients: a single-center analysis
Van Hung Pham, Quốc Thắng Phạm, Minh Nguyen, et al.
Journal of Pathology and Translational Medicine (2025) Vol. 59, Iss. 2, pp. 125-132
Closed Access
Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients
Friedhelm Raue, Karin Frank‐Raue
Recent results in cancer research/Recent Results in Cancer Research (2025), pp. 267-291
Closed Access
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib
Alessandro Prete, Carla Gambale, Virginia Cappagli, et al.
European Journal of Endocrinology (2022) Vol. 187, Iss. 6, pp. 905-915
Closed Access | Times Cited: 18
The Role of the Kinase Inhibitors in Thyroid Cancers
Francesca Cuomo, Claudio Giani, Gilda Cobellis
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1040-1040
Open Access | Times Cited: 14
Exploring blood metabolites and thyroid disorders: a bidirectional mendelian randomization study
Xuan Zhang, Jiating Zhou, Zilan Xie, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system
Zhufeng Chen, Yaqian Mao, Tingting You, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 7
NF1gene inactivation acts as a tumor driver inRET/RAS-negative medullary thyroid carcinomas
Raffaele Ciampi, Teresa Ramone, Cristina Romei, et al.
European Journal of Endocrinology (2023) Vol. 188, Iss. 5, pp. 430-437
Open Access | Times Cited: 7
Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid Cancer
Antonio Matrone, Alessandro Prete, Carla Gambale, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases
Sarah Hamidi, Armeen Mahvash, Mimi I. Hu
JCEM Case Reports (2024) Vol. 2, Iss. 8
Open Access | Times Cited: 2
Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer
Antonio Matrone, Matthias Kroiß, Matti L. Gild, et al.
Thyroid (2024) Vol. 34, Iss. 9, pp. 1177-1180
Closed Access | Times Cited: 2
Diagnostics and treatment of differentiated thyroid carcinoma in children — Guidelines of the Polish National Scientific Societies, 2024 Update
Daria Handkiewicz-Junak, Marek Niedziela, Andrzej Lewiński, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 6, pp. 565-591
Open Access | Times Cited: 2
Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma
Dan‐Feng Weng, Long He, Xiangna Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 6
Using preoperative ultrasound vascularity characteristics to estimate medullary thyroid cancer
Luying Gao, Liyuan Ma, Xiaoyi Li, et al.
Cancer Imaging (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer
Claudia Ricci, Antonia Salvemini, Cristina Dalmiglio, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 4009-4009
Open Access | Times Cited: 5
Insights into highly selective RET inhibitors in medullary thyroid cancer
Antonio Matrone, Rossella Elisei
Current Opinion in Endocrine and Metabolic Research (2024) Vol. 35, pp. 100521-100521
Closed Access | Times Cited: 1
Efficacy and safety of selpercatinib in treating RET-altered MTC: A single-arm meta-analysis
Dongmei Huang, Jinming Zhang, Xiangqian Zheng, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31681-e31681
Open Access | Times Cited: 1
Hand–foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer
Elisa Minaldi, Virginia Cappagli, Loredana Lorusso, et al.
European Thyroid Journal (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 1
Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib
Carla Gambale, Alessandro Prete, Chiara Romei, et al.
European Thyroid Journal (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 1
Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
Davide Saronni, Germano Gaudenzi, Alessandra Dicitore, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4442-4442
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top